Linares L, García-Goez J F, Cervera C, Almela M, Sanclemente G, Cofán F, Ricart M J, Navasa M, Moreno A
Service of Infectious Diseases, Hospital Clínic, Barcelona-IDIBAPS-University of Barcelona, Barcelona, Spain.
Transplant Proc. 2009 Jul-Aug;41(6):2262-4. doi: 10.1016/j.transproceed.2009.06.079.
Bloodstream infections (BSI) are a major cause of morbidity and mortality after solid organ transplantation. Our aim was to analyze early BSI after solid organ transplantation.
A prospective cohort study included patients undergoing a kidney, simultaneous kidney-pancreas (SPK), or orthotopic liver transplantation (OLT) from 2003-2007. We prospectively collected demographic variables, underlying chronic diseases, transplantation procedures, and posttransplant complications. Recorded cases of BSI were defined as significant according to CDC criteria. Early BSIs were considered to be those appearing within 30 days posttransplantation.
During the study period, we performed 902 transplantations: 474 renal, 340 liver, and 88 pancreas. Seventy episodes of early BSI were diagnosed in 67 patients (7.4%). The incidences of BSI according to the type of transplantation were: 4.8% in renal, 4.5% in SPK, and 12% in OLT (P < .001). Sixty-three percent of the bacteria isolated were gram-negative, the most frequent being Escherichia coli, of which 18 (54%) were extended-spectrum beta-lactamase-producing (ESBL), and Pseudomonas aeruginosa, of which 18 (31%) were multidrug-resistant. The most frequent gram-positive bacteria were coagulase-negative staphylococci (20%). The urinary tract was a frequent source of BSI (27%), followed by a catheter (18%). Two patients (3%) died, both liver recipients, but neither death was related to the BSI.
In our setting, the incidence of early BSI among solid organ transplant recipients was high, especially liver recipients, but with low associated mortality. The most frequent sources of infection were urinary tract and catheter. Gram-negative BSI showed a high rate of multidrug resistance.
血流感染(BSI)是实体器官移植后发病和死亡的主要原因。我们的目的是分析实体器官移植后的早期血流感染情况。
一项前瞻性队列研究纳入了2003年至2007年接受肾脏、同期肾胰联合移植(SPK)或原位肝移植(OLT)的患者。我们前瞻性收集了人口统计学变量、潜在慢性疾病、移植手术及移植后并发症。根据美国疾病控制与预防中心(CDC)标准,记录的血流感染病例被定义为有意义。早期血流感染被认为是移植后30天内出现的感染。
在研究期间,我们进行了902例移植手术:474例肾脏移植、340例肝移植和88例胰移植。67例患者(7.4%)被诊断出70例早期血流感染。根据移植类型,血流感染的发生率分别为:肾脏移植4.8%,肾胰联合移植4.5%,肝移植12%(P < .001)。分离出的细菌中63%为革兰氏阴性菌,最常见的是大肠杆菌,其中18株(54%)产超广谱β-内酰胺酶(ESBL),还有铜绿假单胞菌,其中18株(31%)对多种药物耐药。最常见的革兰氏阳性菌是凝固酶阴性葡萄球菌(20%)。泌尿系统是血流感染的常见来源(27%),其次是导管(18%)。两名患者(3%)死亡,均为肝移植受者,但均与血流感染无关。
在我们的研究中,实体器官移植受者中早期血流感染的发生率较高,尤其是肝移植受者,但相关死亡率较低。最常见的感染来源是泌尿系统和导管。革兰氏阴性血流感染显示出较高的多重耐药率。